Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Fiziol Zh (1994) ; 59(5): 78-84, 2013.
Artículo en Ucraniano | MEDLINE | ID: mdl-24400569

RESUMEN

We studied the content of glycoproteins and their individual carbohydrate components, the phagocyte activity of neutrophils, phagocyte index, phagocyte number lizotsym and bactericidal activity of the serum concentration of circulating immune complexes and middle mass molecules in the blood of rabbits following administration into the diet chlorella suspension, sodium sulfate, chromium citrate and chromium chloride. The studies were conducted on rabbits weighing 3.7-3.9 kg with altered diet from the first day of life to 118 days old. Rabbits were divided into five groups: the control one and four experimental groups. We found that in the blood of rabbits of experimental groups recieved sodium sulphate, chromium chloride and chromium citrate, the content of glycoprotein's and their carbohydrate components was significantly higher during the 118 days of the study compared with the control group. Feeding rabbits with mineral supplements likely reflected the differences compared with the control parameters of nonspecific resistance in the blood for the study period, which was more pronounced in the first two months of life.


Asunto(s)
Chlorella/química , Cloruros/administración & dosificación , Compuestos de Cromo/administración & dosificación , Ácido Cítrico/administración & dosificación , Suplementos Dietéticos , Sulfatos/administración & dosificación , Animales , Complejo Antígeno-Anticuerpo/sangre , Ceruloplasmina/metabolismo , Dieta , Femenino , Glicoproteínas/sangre , Haptoglobinas/metabolismo , Hexosas/sangre , Masculino , Neutrófilos/inmunología , Fagocitosis/inmunología , Embarazo , Conejos , Ácidos Siálicos/sangre
2.
J Nutr Biochem ; 24(1): 54-61, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22748805

RESUMEN

OMIC technologies, including transcriptomics and metabolomics, may provide powerful tools for identifying the effects of nutrients on molecular functions and metabolic pathways. The objective was to investigate molecular and metabolic changes following n-3 polyunsaturated fatty acid (PUFA) supplementation in healthy subjects via traditional biomarkers as well as transcriptome and metabolome analyses. Thirteen men and 17 women followed a 2-week run-in period based on Canada's Food Guide and then underwent 6-week supplementation with n-3 PUFA (3 g/day). Traditional biochemical markers such as plasma lipids, inflammatory markers, glycemic parameters and erythrocyte fatty acid concentrations were measured. Changes in gene expression of peripheral blood mononuclear cells were assessed by microarrays, and metabolome profiles were assessed by mass spectrometry assay kit. After supplementation, plasma triglycerides decreased and erythrocyte n-3 PUFA concentrations increased to a similar extent in both genders. Further, plasma high-density lipoprotein cholesterol concentrations and fasting glucose levels increased in women after n-3 PUFA supplementation. N-3 PUFA supplementation changed the expression of 610 genes in men, whereas the expression of 250 genes was altered in women. Pathway analyses indicate changes in gene expression of the nuclear receptor peroxisome proliferator-activated receptor-alpha, nuclear transcription-factor kappaB, oxidative stress and activation of the oxidative stress response mediated by nuclear factor (erythroid-derived 2)-like 2. After n-3 PUFA supplementation, metabolomics profiles demonstrate an increase in acylcarnitines, hexose and leucine in men only and a decrease in saturation of glycerophosphatidylcholine and lysophosphatidylcholine concentrations in all subjects. Overall, traditional and novel biomarkers suggest that n-3 PUFA supplementation exerts cardioprotective effects.


Asunto(s)
Cardiotónicos/farmacología , Colesterol/sangre , Ácidos Grasos Omega-3/farmacología , Lípidos/sangre , Adulto , Glucemia/análisis , Suplementos Dietéticos , Eritrocitos/efectos de los fármacos , Eritrocitos/metabolismo , Ácidos Grasos/sangre , Ácidos Grasos Omega-3/sangre , Femenino , Perfilación de la Expresión Génica , Hexosas/sangre , Humanos , Inflamación/metabolismo , Inflamación/prevención & control , Leucina/sangre , Masculino , Metabolómica/métodos , Quebec , Valores de Referencia , Población Blanca
3.
Asian Pac J Trop Med ; 5(12): 939-44, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23199710

RESUMEN

OBJECTIVE: To investigate the protective role of Cardiospermum halicacabum (C. halicacabum) leaf extract on glycoprotein metabolism in streptozotocin (STZ)-induced diabetic rats. METHODS: Diabetes was induced in male albino Wistar rats by intraperitonial administration of STZ. The C. halicacabum leaf extract (CHE) was administered orally to normal and STZ-diabetic rats for 45 days. The effects of C. halicacabum leaf extract (CHE) on plasma and tissue glycoproteins (hexose, hexosamine, fucose and sialic acid) were determined. RESULTS: The levels of plasma and tissues glycoproteins containing hexose, hexosamine and fucose were significantly increased in STZ-induced diabetic rats. In addition, the level of sialic acid significantly increased in plasma and liver while decreased in kidney of STZ-induced diabetic rats. After administration of CHE to diabetic rats, the metabolic alteration of glycoprotein reverted towards normal levels. CONCLUSIONS: The present study indicates that the CHE possesses a protective effect on abnormal glycoprotein metabolism in addition to its antihyperglycemic activity.


Asunto(s)
Metabolismo de los Hidratos de Carbono/efectos de los fármacos , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/metabolismo , Hiperglucemia/tratamiento farmacológico , Extractos Vegetales/farmacología , Sustancias Protectoras/farmacología , Sapindaceae/química , Análisis de Varianza , Animales , Glucemia/efectos de los fármacos , Diabetes Mellitus Experimental/sangre , Fucosa/sangre , Fucosa/metabolismo , Glicoproteínas/metabolismo , Hexosaminas/sangre , Hexosaminas/metabolismo , Hexosas/sangre , Hexosas/metabolismo , Hiperglucemia/sangre , Hiperglucemia/inducido químicamente , Hiperglucemia/metabolismo , Riñón/química , Riñón/metabolismo , Hígado/química , Hígado/metabolismo , Masculino , Ácido N-Acetilneuramínico/sangre , Ácido N-Acetilneuramínico/metabolismo , Hojas de la Planta/química , Ratas , Ratas Wistar
4.
Cancer Sci ; 97(7): 658-64, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16827807

RESUMEN

Lung cancer is one of the leading causes of cancer death in the world and is notoriously difficult to treat effectively. In the present study, male Swiss albino mice were divided into five groups of six animals each: group I animals received corn oil orally and served as a control; group II cancer-induced animals received benzo(a)pyrene (50 mg/kg bodyweight dissolved in corn oil, orally) twice weekly for four successive weeks; group III cancer-bearing animals (after 12 weeks of induction) were treated with paclitaxel (33 mg/kg bodyweight, i.p.) once weekly for 4 weeks; group IV cancer-bearing animals were treated with paclitaxel along with Withania somnifera (400 mg/kg bodyweight) orally once weekly for 4 weeks; and group V animals constituted the drug control treated with paclitaxel along with W. somnifera. The serum, lung and liver were investigated biochemically for aryl hydrocarbon hydroxylase, gamma-glutamyl transpeptidase, 5'-nucleotidase, lactate dehydrogenase and protein-bound carbohydrate components (hexose, hexosamine and sialic acid). These enzyme activities were increased significantly in cancer-bearing animals compared with control animals. The elevation of these in cancer-bearing animals was indicative of the persistent deteriorating effect of benzo(a)pyrene in cancer-bearing animals. Our data suggest that paclitaxel, administered with W. somnifera, may extend its chemotherapeutic effect through modulating protein-bound carbohydrate levels and marker enzymes, as they are indicators of cancer. The combination of paclitaxel with W. somnifera could effectively treat the benzo(a)pyrene-induced lung cancer in mice by offering protection from reactive oxygen species damage and also by suppressing cell proliferation.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias Pulmonares/tratamiento farmacológico , Paclitaxel/uso terapéutico , Fitoterapia , Extractos Vegetales/uso terapéutico , Withania/química , 5'-Nucleotidasa/análisis , Animales , Hidrocarburo de Aril Hidroxilasas/análisis , Benzo(a)pireno , Biomarcadores de Tumor/análisis , Biomarcadores de Tumor/sangre , Peso Corporal , Glicoproteínas/análisis , Hexosaminas/análisis , Hexosaminas/química , Hexosas/análisis , Hexosas/sangre , L-Lactato Deshidrogenasa/análisis , L-Lactato Deshidrogenasa/sangre , Pulmón/enzimología , Neoplasias Pulmonares/inducido químicamente , Masculino , Ratones , Ácido N-Acetilneuramínico/análisis , Ácido N-Acetilneuramínico/sangre , Preparaciones de Plantas/uso terapéutico , Raíces de Plantas/química , Poliaminas/análisis , Carga Tumoral , gamma-Glutamiltransferasa/análisis
5.
Pharmazie ; 60(3): 229-32, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15801680

RESUMEN

The present study was aimed to evaluate the role of the indigenous antidiabetic medicinal plant Casearia esculenta on glycoprotein components in streptozotocin-induced diabetic rats in plasma, liver, kidney and cardiac tissues. Streptozotocin injection (50 mg/kg body weight) caused massive elevation of glycoprotein components such as hexose, hexosamine, sialic acid and fucose in plasma and tissues of diabetic control and experimental animals. Oral administration of C. esculenta root extract (200 and 300 mg/kg body weight) for 45 days significantly reverted the hexose, hexosamine, sialic acid and fucose levels to near normal values. These results suggest a normalizing effect of C. esculenta on glycoprotein components in STZ diabetic rats.


Asunto(s)
Casearia/química , Diabetes Mellitus Experimental/metabolismo , Glicoproteínas/metabolismo , Animales , Diabetes Mellitus Experimental/sangre , Fucosa/metabolismo , Glicoproteínas/sangre , Corazón/efectos de los fármacos , Hexosas/sangre , Riñón/efectos de los fármacos , Riñón/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Miocardio/metabolismo , Ácido N-Acetilneuramínico/metabolismo , Extractos Vegetales/farmacología , Raíces de Plantas/química , Ratas , Ratas Wistar
6.
Pharmacol Res ; 48(2): 167-73, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12798669

RESUMEN

Selenium in the form of sodium selenite is an essential micronutrient, that acts as an antioxidant/anticancer agent by its numerous macromolecules associated with them. This study emphasizes further evidence on its role as anticancer agent in experimental rats with N-nitrosodiethylamine (DEN) initiated (200 mg kg(-1) body weight) and phenobarbital (PB) promoted hepatoma. Serum, whole liver tissue (control animals, n=6), hepatoma and surrounding liver tissue samples from DEN-treated rats and rats supplemented with selenite (n=6) were collected. Total protein, albumin, globulin and albumin/globulin ratio were investigated. Hexose, hexosamine and sialic acid were also quantified. Animals treated with DEN resulted in significantly decreased levels of total protein, albumin and albumin/globulin ratio; on the other hand, globulin content was increased significantly when compared to control rats. We have also observed significant increased levels of hexose, hexosamine and sialic acid in serum, whole liver tissue (control), hepatoma and surrounding liver tissue of control and experimental animals. Supplementation of selenite (4 ppm) either before initiation, during initiation and/or during promotion stages alters the above biochemical changes significantly. Thus, supplementations of selenite in cancer bearing animals reduce the adverse changes that occur during cancer condition. However, the chemopreventive/chemotherapeutic effect of selenite is more pronounced when it was supplemented before and/or during initiation of cancer when compared to promotion stage. Our results emphasize the role of sodium selenite in cancer and strongly indicate its role as an essential micronutrient in cancer chemoprevention and therapy.


Asunto(s)
Carcinoma Hepatocelular/tratamiento farmacológico , Glicoproteínas/efectos de los fármacos , Neoplasias Hepáticas Experimentales/tratamiento farmacológico , Selenito de Sodio/farmacología , Animales , Biomarcadores/análisis , Proteínas Sanguíneas/análisis , Carcinoma Hepatocelular/inducido químicamente , Dietilnitrosamina , Glicoproteínas/análisis , Hexosaminas/sangre , Hexosas/sangre , Hígado/química , Neoplasias Hepáticas Experimentales/inducido químicamente , Masculino , Ácido N-Acetilneuramínico/sangre , Fenobarbital , Ratas , Ratas Wistar , Albúmina Sérica/análisis , Seroglobulinas/análisis , Selenito de Sodio/uso terapéutico , Análisis de Supervivencia
7.
Br J Nutr ; 74(1): 19-26, 1995 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-7547825

RESUMEN

Postprandial kinetics of porto-arterial concentration differences of glucose (G), galactose (Gal), L-lactic acid (LA) and amino-N (AN) were studied in the piglet after the ingestion of 10(7) colony-forming units (cfu) Sporolactobacillus P44 (SP), or 10(6) cfu Bacillus cereus IP5832 (AC), or 10(6) cfu of a combination of Lactobacillus acidophilus, L. fermentum and L. brevis (AB)/g feed. Sixteen fistulated piglets (portal vein and brachiocephalic trunk; mean body weight 22 (SD 2) kg) were used. The diet was based on skimmed milk (320 g/kg), barley (300 g/kg), wheat bran (110 g/kg), maize (100 g/kg) and lactose (70 g/kg). The postprandial blood kinetics, four measurements per animal at 1-week intervals, were studied for 6 h after the ingestion of test meals of 400 g basal diet (BD) or this diet supplemented with the bacteria (SP, AC and AB respectively). Areas of porto-arterial concentration differences (APACD) of G, Gal and LA were not influenced by the bacteria supplements. APACD of AN was significantly higher after the ingestion of the SP diet than that estimated for BD.


Asunto(s)
Aminoácidos/química , Alimentación Animal , Bacterias , Hexosas/sangre , Nitrógeno/sangre , Porcinos/sangre , Animales , Bacillus cereus , Glucemia/metabolismo , Digestión , Galactosemias/sangre , Cinética , Lactatos/sangre , Ácido Láctico , Lactobacillus , Hígado/irrigación sanguínea , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA